International day for fighting infection sees European infection specialists advocating vaccines as a viable solution to tackle antimicrobial resistance.
World Health Organization (WHO) has joined forces with the European Society for Clinical Microbiology and Infectious Diseases (ESCMID) to launch the seventh annual “International Day for Fighting Infection,” to be held on April 24, 2015. During the event, experts will explore the use of vaccines as a possible solution in the global, cross-border fight against antimicrobial resistance.
The event is free to attend and coincides with the ESCMID annual congress (ECCMID) in Copenhagen and WHO’s “World Immunization Week.” This initiative serves as a platform to increase international collaboration as well as highlight cutting-edge methods to tackle infectious disease.
WHO will be providing an update from its European office across Ebola, extensively drug-resistant tuberculosis, and polio, while ESCMID will explore how vaccines can be harnessed to combat antimicrobial resistance.
Following “International Day for Fighting Infection” will be the 25th European Congress of Clinical Microbiology and Infectious Diseases, which will be held from April 25–28, 2015.
More details on the event can be found at www.escmid.org/research_projects/escmid_conferences/7th_international_day_for_fighting_infection/.
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.
Exosomes Field Advances with Milestones Achieved by EXO Biologics and ExoXpert
December 4th 2024EXO Biologics and ExoXpert, an EXO Biologics subsidiary, have received GMP certification of a European manufacturing facility for exosomes and have successfully loaded mRNA and DNA payloads into GMP-grade exosomes for drug delivery.